Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch
PHASE1
This study is intended to produce information on the pharmacokinetic charac...
A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants
PHASE1
This study of healthy participants evaluated the concentration of a test LY...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
PHASE1
The study will be conducted in participants with type1 diabetes on insulin ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects
PHASE1
The primary objective of this pilot study is to determine the within-subjec...